Maimon Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.53M Buy
+1,325
New +$1.56M 1.06% 29
2026
Q2
– Sell
-1,327
Closed -$1.18M – 83
2026
Q1
$1.18M Hold
1,327
– – 1.03% 29
2025
Q4
$1.43M Buy
+1,327
New +$1.27M 1.33% 27

Other funds holding LLY

Maimon Wealth Management's LLY Position: Q3 2026 in Review

Maimon Wealth Management opened a new position in Eli Lilly (LLY) in Q3 2026: 1,325 shares worth $1.53M. The stake represents 1.06% of the portfolio and ranks #29 among its holdings. This is a return to the name: Maimon Wealth Management previously reported a position in LLY as recently as Q1 2026.

Maimon Wealth Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Maimon Wealth Management held 1,325 shares of Eli Lilly worth $1.53M as of Q3 2026.
  • Eli Lilly was a new Maimon Wealth Management position in Q3 2026.
  • Eli Lilly made up 1.06% of Maimon Wealth Management's portfolio in Q3 2026, its #29 holding.
  • Maimon Wealth Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Maimon Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.